|
E.F. Gaisina, E.A. Basova, M.A. Frolova, A.S. Goskov
Countermeasures to the use of narcotic analgesics as pharmacological doping by athletes
|
№9/10 / 2023
|
|
A.I. Listratov, O.D. Ostroumova, N.L. Lyakhova
Drugs, the use of which is associated with the development of drug-induced kidney stone disease. Part 2
|
№11-12 / 2022
|
|
A.I. Listratov, O.D. Ostroumova, A.G. Komarova
Drugs, the use of which is associated with the development of drug-induced kidney stone disease. Part 1
|
№6 / 2022
|
|
A.I. Listratov, O.D. Ostroumova, S.N. Litvinova
Drug-induced kidney stone disease
|
№6 / 2022
|
|
A.P. Pereverzev (1), O.D. Ostroumova (1, 2), D.A. Sychev (1)
Interactions between alcohol and drugs: focus on drugs used to treat diseases of the cardiovascular system, gastrointestinal tract, antimicrobial drugs
|
№13 / 2021
|
|
A.P. Pereverzev (1), O.D. Ostroumova (1, 2), D.A. Sychev (1)
Drug-alcohol interactions: focus on central-acting drugs and analgesics
|
№13 / 2021
|
|
D.A. Sychev (1), O.D. Ostroumova (1, 2), A.I. Kochetkov (1), A.P. Pereverzev (1), T.M. Ostroumova (2), M.V. Klepikova (1), E.Yu. Ebzeeva (1)
Medication errors as risk factor for drug-induced diseases
|
№11 / 2021
|
|
D.A. Sychev (1), O.D. Ostroumova (1, 2), A.P. Pereverzev (1), A.I. Kochetkov (1), T.M. Ostroumova (2), M.V. Klepikova (1), E.Yu. Ebzeeva (1)
Tobacco smoking as a risk factor for the development of drug-induced diseases
|
№5 / 2021
|
|
L.N. Drobotko, T.E. Zueva, L.P. Kiselnikova
Teething syndrome: when and how to treat
|
№10 / 2019
|
|
A.L. Zaplatnikov, A.A. Girina, N.V. Koroid, N.S. Glukhareva
Rational Therapy Of Cough In Infectious And Inflammatory Respiratory Diseases In Children
|
№4 / 2013
|
|
A. Pischita
Medico-legal Regulations Of Drug Therapy Implementation In The Frames Of Current Legislation Of Rf
|
№5 / 2010
|
|
E.A. Volskaya
Legal Aspects Of The Prescription Of Drags For Off-label-use
|
№6 / 2009
|
Русский
